XML 41 R28.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Note 9 - Earnings Per Share (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2021
Notes Tables |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
|  | Quarter Ended |  |  | Six Months Ended |
|  | December 31, |  |  | December 31, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Earnings per share – basic: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net earnings, including noncontrolling interest |  | $ | 72,059 |  |  | $ | 46,144 |  |  | $ | 141,040 |  |  | $ | 79,538 |
Less net earnings (loss) attributable to noncontrolling interest |  |  | (8,114 | ) |  |  | (130 | ) |  |  | (8,748 | ) |  |  | (130 | )
Net earnings attributable to Bio-Techne |  | $ | 80,173 |  |  | $ | 46,274 |  |  | $ | 149,788 |  |  | $ | 79,668 |
Income allocated to participating securities |  |  | (34 | ) |  |  | (37 | ) |  |  | (70 | ) |  |  | (50 | )
Income available to common shareholders |  | $ | 80,139 |  |  | $ | 46,237 |  |  | $ | 149,718 |  |  | $ | 79,618 |
Weighted-average shares outstanding – basic |  |  | 39,310 |  |  |  | 38,691 |  |  |  | 39,202 |  |  |  | 38,614 |
Earnings per share – basic |  | $ | 2.04 |  |  | $ | 1.20 |  |  | $ | 3.82 |  |  | $ | 2.06 |
Earnings per share – diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net earnings, including noncontrolling interest |  | $ | 72,059 |  |  | $ | 46,144 |  |  | $ | 141,040 |  |  | $ | 79,538 |
Less net earnings (loss) attributable to noncontrolling interest |  |  | (8,114 | ) |  |  | (130 | ) |  |  | (8,748 | ) |  |  | (130 | )
Net earnings attributable to Bio-Techne |  | $ | 80,173 |  |  | $ | 46,274 |  |  | $ | 149,788 |  |  | $ | 79,668 |
Income allocated to participating securities |  |  | (34 | ) |  |  | (37 | ) |  |  | (70 | ) |  |  | (50 | )
Income available to common shareholders |  | $ | 80,139 |  |  | $ | 46,237 |  |  | $ | 149,718 |  |  | $ | 79,618 |
Weighted-average shares outstanding – basic |  |  | 39,310 |  |  |  | 38,691 |  |  |  | 39,202 |  |  |  | 38,614 |
Dilutive effect of stock options and restricted stock units |  |  | 1,897 |  |  |  | 1,566 |  |  |  | 1,957 |  |  |  | 1,521 |
Weighted-average common shares outstanding – diluted |  |  | 41,207 |  |  |  | 40,257 |  |  |  | 41,159 |  |  |  | 40,135 |
Earnings per share – diluted |  | $ | 1.94 |  |  | $ | 1.15 |  |  | $ | 3.64 |  |  | $ | 1.98 |

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration